Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TSXV/QPT stock hub

TSXV/QPT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSXV/QPTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.8M

TSX Venture Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSXV/QPT

In the news

Latest news · TSXV/QPT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-0.4

P25 -121.5P50 -40.9P75 0.5

ROIC-2.1

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSXV/QPT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

133

Groups with data

Currency

CAD

Showing 133 of 133 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 7.7M
Exchange	TSX Venture Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA74836M1068
Last refreshed	2026-05-10
Market cap	CAD 6.8M
Price	CAD 0.04
Price currency	CAD
Sector	Healthcare
Sic	2834
Symbol	tsxv/QPT
Website	https://www.questpharmatech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.43%
EV Earnings	-79.78x
P/B ratio	0.29x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	CAD -96,600
Net Income Growth Q	3,005.53%
ROA	-2.04
Roa5y	-1.48
ROCE	-3.43
ROE	-0.42
Roe5y	8.65
ROIC	-2.05

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-3.97%
Cagr15y	0.89%
Cagr1y	-11.12%
Cagr20y	-4.23%
Cagr3y	-18.9%
Cagr5y	-18.32%
EPS Growth Q	3,010.2

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	CAD 24.3M
Cash	CAD 58,241
Current Assets	CAD 83,704
Current Liabilities	CAD 1.3M
Debt	CAD 1M
Debt Equity	CAD 0.04
Equity	CAD 23.1M
Interest Coverage	-51.36
Liabilities	CAD 1.3M
Long Term Assets	CAD 24.2M
Long Term Liabilities	CAD 0
Net Cash	CAD -941,759
Net Cash By Market Cap	CAD -13.92
Net Debt Equity	CAD 0.04
Tangible Book Value	CAD 23.1M
Tangible Book Value Per Share	CAD 0.14
WACC	2.64

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.07
Net Working Capital	CAD -228,401
Quick ratio	0.05
Working Capital	CAD -1.2M

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-33.33%
1Y total return	-11.11%
200-day SMA	0.04
3Y total return	-46.67%
50-day SMA	0.03
50-day SMA vs 200-day SMA	50under200
5Y total return	-63.64%
All Time High	3
All Time High Change	-98.67%
All Time High Date	2000-03-06
All Time Low	0.02
All Time Low Change	166.67%
All Time Low Date	2008-12-23
ATR	0
Beta	-0.25
Beta1y	0.17
Beta2y	-1.93
Ch YTD	14.29
High	0.04
High52	0.06
High52 Date	2025-06-10
High52ch	-27.27%
Low	0.04
Low52	0.03
Low52 Date	2026-04-09
Low52ch	60%
Ma50ch	19.76%
Price vs 200-day SMA	8.99%
RSI	60.52
RSI Monthly	50.15
RSI Weekly	54.32
Sharpe ratio	1.34x
Sortino ratio	2.3
Tr YTD	14.29
Tr15y	14.29%
Tr1m	33.33%
Tr3m	33.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -791,347

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	138,748,729%
Shares Insiders	3.18%
Shares Out	169,129,247
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	60,872.35x
Bv Per Share	0.14
Ch10y	-33.33
Ch15y	14.29
Ch1m	33.33
Ch1y	-11.11
Ch20y	-57.89
Ch3m	33.33
Ch3y	-46.67
Ch5y	-63.64
Change	0%
Change From Open	0
Close	0.04
Days Gap	0
Dollar Volume	80
Earnings Date	2026-05-29
EBIT	CAD -791,347
EPS	CAD -0
F Score	0
Fiscal Year End	January
Is Primary Listing	1
Last Earnings Date	2025-12-19
Last Report Date	2025-10-31
Ma150	0.04
Ma150ch	8.7%
Ma20	0.03
Ma20ch	21.95%
Net CF	-128,115
Next Earnings Date	2026-05-29
Open	0.04
Price Date	2026-05-08
Ptbv Ratio	0.29
Relative Volume	0.03x
Share Based Comp	80,000
Tr20y	-57.89%
Volume	2,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSXV/QPT pay a dividend?

Capital-return profile for this ticker.

Performance

TSXV/QPT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSXV/QPT?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+3.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

TSXV/QPT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.5

Neutral momentum band

Price vs 200-day MA

+9.0%

50/200-day relationship not available

Beta (5Y)

-0.25

Less volatile than the market

Sharpe ratio

1.34

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSXV/QPT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsxv/QPT stock rating?

tsxv/QPT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsxv/QPT analysis?

The full report lives at /stocks/tsxv/QPT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsxv/QPT?

The latest report frames tsxv/QPT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsxv/QPT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.